Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T T Le

Showing results (181-190 of 195) with videos related to

Pageof 20
Sort By:
Nature Biomedical Engineering|August 26, 2024
Standardizing designed and emergent quantitative features in microphysiological systemsDennis M Nahon, Renée Moerkens, Hande Aydogmus, et al.
Science (New York, N.Y.)|November 22, 2014
Antibody landscapes after influenza virus infection or vaccinationJ M Fonville, S H Wilks, S L James, et al.
Journal of Thoracic Disease|September 28, 2019
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1)Jean Bousquet, Nhân Pham-Thi, Anna Bedbrook, et al.
Journal of Thoracic Disease|October 29, 2019
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2)Jean Bousquet, Nhân Pham-Thi, Anna Bedbrook, et al.
The Lancet Regional Health. Western Pacific|May 23, 2022
Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trialThuy P Nguyen, Quyet Do, Lan T Phan, et al.
Allergy|March 26, 2008
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)J Bousquet, N Khaltaev, A A Cruz, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2018
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technologyJean Bousquet, Peter W Hellings, Ioana Agache, et al.
Allergy|December 20, 2018
ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration projectSinthia Bosnic-Anticevich, Elisio Costa, Enrica Menditto, et al.
Allergy|April 3, 2021
Management of anaphylaxis due to COVID-19 vaccines in the elderlyJean Bousquet, Ioana Agache, Hubert Blain, et al.
Clinical and Translational Allergy|September 14, 2019
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseasesJ Jean Bousquet, Holger J Schünemann, Alkis Togias, et al.
Pageof 20

Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
Nature Biomedical Engineering|August 26, 2024
Standardizing designed and emergent quantitative features in microphysiological systemsDennis M Nahon, Renée Moerkens, Hande Aydogmus, et al.
Science (New York, N.Y.)|November 22, 2014
Antibody landscapes after influenza virus infection or vaccinationJ M Fonville, S H Wilks, S L James, et al.
Journal of Thoracic Disease|September 28, 2019
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1)Jean Bousquet, Nhân Pham-Thi, Anna Bedbrook, et al.
Journal of Thoracic Disease|October 29, 2019
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2)Jean Bousquet, Nhân Pham-Thi, Anna Bedbrook, et al.
The Lancet Regional Health. Western Pacific|May 23, 2022
Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trialThuy P Nguyen, Quyet Do, Lan T Phan, et al.
Allergy|March 26, 2008
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)J Bousquet, N Khaltaev, A A Cruz, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2018
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technologyJean Bousquet, Peter W Hellings, Ioana Agache, et al.
Allergy|December 20, 2018
ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration projectSinthia Bosnic-Anticevich, Elisio Costa, Enrica Menditto, et al.
Allergy|April 3, 2021
Management of anaphylaxis due to COVID-19 vaccines in the elderlyJean Bousquet, Ioana Agache, Hubert Blain, et al.
Clinical and Translational Allergy|September 14, 2019
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseasesJ Jean Bousquet, Holger J Schünemann, Alkis Togias, et al.
Pageof 20